Correlation Between Hepion Pharmaceuticals and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Crispr Therapeutics AG, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Crispr Therapeutics.
Diversification Opportunities for Hepion Pharmaceuticals and Crispr Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hepion and Crispr is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Crispr Therapeutics
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Crispr Therapeutics. In addition to that, Hepion Pharmaceuticals is 4.32 times more volatile than Crispr Therapeutics AG. It trades about -0.11 of its total potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.07 per unit of volatility. If you would invest 4,048 in Crispr Therapeutics AG on October 23, 2024 and sell it today you would earn a total of 103.00 from holding Crispr Therapeutics AG or generate 2.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Crispr Therapeutics |
Hepion Pharmaceuticals and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Crispr Therapeutics
The main advantage of trading using opposite Hepion Pharmaceuticals and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |